TransCode Therapeutics In... (RNAZ)

AI Score

Unlock

0.39

0.08 (24.20%)

At close: Apr 24, 2025, 3:59 PM

0.40

1.65%

After-hours: Apr 24, 2025, 07:59 PM EDT

TransCode Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019
Net Income	-5.92M	-2.32M	-5.19M	-3.33M	-4.09M	-5.3M	-4.34M	-4.82M	-5.13M	-4.29M	-4.67M	-3.47M	-2.8M	-2.33M	2.77M	-4.49M	-801.53K	-1.37M	-127.2K	-41.26K	-195.59
Depreciation & Amortization	122.86K	127.52K	142.83K	141.65K	140.17K	138.78K	137.59K	100.2K	29.5K	24.8K	22.7K	21.6K	28.99K	7.54K	4.69K	1.25K	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	168.77K	204.48K	1.14M	183.15K	310.31K	392.33K	175.48K	158.76K	130.56K	105.6K	98.6K	60.57K	39K	64.05K	34.51K	48.43K	12.66K	31.38K	699.00	698.00	0.70
Other Working Capital	930.4K	-779.62K	656.32K	-250.72K	61.26K	-696.06K	1.38M	-531.56K	344.82K	-2.3K	1.3M	117.26K	572.84K	-2.28M	292.41K	-442.46K	33.82K	33.82K	32.47K	18.4K	14.04
Other Non-Cash Items	1.54M	n/a	n/a	1.15M	2.68M	-1.15M	2.06M	-577.05K	1.31B	2.03K	265.92K	781.7K	35.69K	-35.35K	19.51K	19.63K	388.73K	1.1M	3.18K	3.18K	53.11
Deferred Income Tax	n/a	n/a	n/a	n/a	-2.68M	1.15M	-2.06M	577.05K	-1.31B	n/a	-265.92K	n/a	3.08K	1.34K	-3.11M	3.98M	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	942.35K	-1.92M	1.56M	-935.21K	-2.03M	1.26M	-363.12K	44.42K	954.27K	-262.82K	1.18M	-560.67K	1.09M	-775.85K	205.73K	-89.25K	144.64K	111.06K	34.81K	19.25K	14.04
Operating Cash Flow	-3.15M	-3.91M	-2.34M	-3.94M	-5.66M	-3.51M	-4.39M	-4.51M	-4.02M	-4.42M	-3.37M	-3.95M	-1.6M	-3.07M	-76K	-522.15K	-255.49K	-130.84K	-88.51K	-18.13K	-127.74
Capital Expenditures	-500	-12.87K	-4.55K	-3.84K	35.61K	-4.61K	-18.11K	-12.9K	-28.21K	n/a	-42.05K	-30.66K	-85.73K	-71.55K	-22.24K	-75.3K	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	-3.84K	-35.61M	n/a	n/a	-12.9M	-100.89M	n/a	n/a	-30.66M	3K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-500	-12.87K	-4.55K	-3.84K	-35.57M	-4.61K	-18.11K	-12.9K	-28.21K	n/a	-42.05K	-30.66K	-82.73K	-71.55K	-22.24K	-75.3K	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	190K	1M	200K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	n/a	n/a	n/a	135.8K	-135.8K	n/a	225.82K	-225.82K	5.98K	5.99K	9.48K	25.56M	78.84K	-131.6K	-12.43K	-61.05K	n/a	n/a	-199.8K
Financial Cash Flow	7.08M	2.45M	785.2K	6.09M	978.15K	7.39M	6.36M	1.18M	225.82K	-225.82K	5.98K	5.99K	9.48K	25.56M	78.84K	-131.6K	-12.43K	-61.05K	190K	1M	200.00
Net Cash Flow	3.94M	-1.48M	-1.56M	2.15M	-4.69M	3.88M	1.95M	-3.35M	-3.82M	-4.65M	-3.41M	-3.97M	-1.67M	22.42M	-19.39K	-729.05K	-267.92K	-191.89K	101.49K	981.87K	72.26
Free Cash Flow	-3.15M	-3.93M	-2.34M	-3.94M	-5.63M	-3.51M	-4.41M	-4.53M	-4.05M	-4.42M	-3.41M	-3.98M	-1.69M	-3.14M	-98.24K	-597.45K	-255.49K	-130.84K	-88.51K	-18.13K	-127.74